Invention Grant
- Patent Title: Triazole derivatives which inhibit vasopressin antagonistic activity
- Patent Title (中): 抑制加压素拮抗活性的三唑衍生物
-
Application No.: US10588876Application Date: 2005-01-11
-
Publication No.: US07449462B2Publication Date: 2008-11-11
- Inventor: Justin S. Bryans , Patrick S. Johnson , Thomas Ryckmans , Alan Stobie
- Applicant: Justin S. Bryans , Patrick S. Johnson , Thomas Ryckmans , Alan Stobie
- Applicant Address: US NY New York
- Assignee: Pfizer, Inc.
- Current Assignee: Pfizer, Inc.
- Current Assignee Address: US NY New York
- Agent Gregg C. Benson; John A. Wichtowski
- Priority: GB0401384.3 20040122
- International Application: PCT/IB2005/000079 WO 20050111
- International Announcement: WO2005/079808 WO 20050901
- Main IPC: C07D401/14
- IPC: C07D401/14 ; A61K31/5517

Abstract:
Compounds of formula (I), or pharmaceutically acceptable derivatives thereof, wherein: Het represents 2-pyridinyl or 2-pyrimidinyl; R1 represents H, C1-3 alkyl or a nitrogen-containing heterocyclic ring having 5 or 6 ring atoms; R2 represents H, benzyl or C1-3 alkyl; and R3 represents H, methyl, methoxy or chloro; are useful for treating anxiety, cardiovascular disease (including angina, atherosclerosis, hypertension, heart failure, edema, hypernatremia), dysmenorrhoea (primary and secondary), endometriosis, emesis (motion sickness), intrauterine growth retardation, inflammation (including rheumatoid arthritis), mittlesmerchz, preclampsia, premature ejaculation, premature (preterm) labor and Raynaud's disease.
Public/Granted literature
- US20070203132A1 Triazole derivatives which inhibit vasopressin antagonistic activity Public/Granted day:2007-08-30
Information query